Status:

UNKNOWN

Study of Standardized Treatment of Integrative Medicine With the Severe IgA Nephropath

Lead Sponsor:

Shanghai University of Traditional Chinese Medicine

Collaborating Sponsors:

Shanghai 6th People's Hospital

RenJi Hospital

Conditions:

IgA Nephropathy

Eligibility:

All Genders

18-60 years

Phase:

NA

Brief Summary

IgA nephropathy(IgAN) is the highest incidence of kidney pathology in the primary nephropathy. In terms of differences in prognosis, severe IgA nephropathy,one of the most main primary renal disease,c...

Eligibility Criteria

Inclusion

  • Confirmed by renal biopsy and clinical examination as primary IgA nephropathy.
  • Pathology:upon Lee's grade Ⅲ
  • Age :18-60 years old.
  • Gender and nationality are not limited
  • Chronic Kidney Disease(CKD) Stage 3:(59 ml/min\>GFR\>30ml/min/1.73m2)
  • 24-hour urine protein:≥1.0g.Informed consent

Exclusion

  • Patients within the past 3 months had received immunosuppressive agents or cytotoxic therapy is greater than 4 weeks
  • Patients within the past 3 months who have received corticosteroids (prednisone or prednisolone) dose of more than 20mg / d up to 4 weeks
  • Patients suffering from acute or rapidly progressive glomerulonephritis
  • Patients continue with active hepatitis B and abnormal liver function tests transaminase
  • Patients with a history of malignant tumor or malignancy, HIV infection, history of mental illness, acute central nervous system disorders, severe gastrointestinal disease, prohibiting the use of immunosuppressive agents
  • Abnormal glucose metabolism, fasting blood glucose more than 6.2mmol/L
  • Pregnancy or breast-feeding women
  • Receiving other clinical trials
  • Associated with other serious diseases and organ dysfunction
  • Combined life-threatening complications such as severe infection

Key Trial Info

Start Date :

January 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT01879514

Start Date

January 1 2010

Last Update

June 17 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Nephrology,Longhua Hospital

Shanghai, China, 200032